Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice - PubMed (original) (raw)
Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice
Stefan Engelhardt et al. Circ Res. 2002.
Abstract
Chronic stimulation of the beta(1)-adrenergic receptor leads to hypertrophy and heart failure in beta(1)-adrenergic receptor transgenic mice and contributes to disease progression in heart failure patients. The cellular mechanisms underlying these detrimental effects are largely unknown. In this study, we have identified the cardiac Na(+)-H(+) exchanger (NHE1) as a novel mediator of adrenergically induced heart failure. beta(1)-Adrenergic receptor transgenic mice showed upregulation of both NHE1 mRNA (+140+/-6%) and protein (+42+/-19%). In order to test whether increased NHE1 is causally related to beta(1)-adrenergic-induced hypertrophy, fibrosis, and heart failure, beta(1)-adrenergic receptor transgenic (TG) and wild-type (WT) littermates were treated with a diet containing 6000 ppm of the NHE1 inhibitor cariporide or control chow for 8 months. There was significant hypertrophy of cardiac myocytes in beta(1)-adrenergic receptor transgenic mice (2.3-fold increase in myocyte cross-sectional area), which was virtually absent in cariporide-fed animals. Interstitial fibrosis was prominent throughout the left ventricular wall in nontreated beta(1)-adrenergic receptor transgenic mice (4.8-fold increase in collagen volume fraction); cariporide treatment completely prevented this development of fibrosis. Left ventricular catheterization showed that cariporide also prevented the loss of contractile function in beta(1)-adrenergic receptor transgenic mice: whereas untreated transgenic mice showed a significant decrease in left ventricular contractility (5250+/-570 mm Hg/s TG versus 7360+/-540 mm Hg/s WT, dp/dt(max)), this decrease was completely prevented by cariporide (8150+/-520 mm Hg/s TG cariporide). Inhibition of NHE1 prevented the development of heart failure in beta(1)-receptor transgenic mice. We conclude that the cardiac Na(+)-H(+) exchanger 1 is essential for the detrimental cardiac effects of chronic beta(1)-receptor stimulation in the heart.
Comment in
- Na(+)-H(+) exchanger inhibition: a new antihypertrophic tool.
Cingolani HE, Camilión de Hurtado MC. Cingolani HE, et al. Circ Res. 2002 Apr 19;90(7):751-3. doi: 10.1161/01.res.0000016836.24179.ae. Circ Res. 2002. PMID: 11964365 No abstract available.
Similar articles
- Na(+)/H(+) exchange inhibition reduces hypertrophy and heart failure after myocardial infarction in rats.
Kusumoto K, Haist JV, Karmazyn M. Kusumoto K, et al. Am J Physiol Heart Circ Physiol. 2001 Feb;280(2):H738-45. doi: 10.1152/ajpheart.2001.280.2.H738. Am J Physiol Heart Circ Physiol. 2001. PMID: 11158973 - Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY, Iwata Y, Arai Y, Komamura K, Wakabayashi S. Nakamura TY, et al. Circ Res. 2008 Oct 10;103(8):891-9. doi: 10.1161/CIRCRESAHA.108.175141. Epub 2008 Sep 5. Circ Res. 2008. PMID: 18776042 - Regression of hypertensive myocardial fibrosis by Na(+)/H(+) exchange inhibition.
Cingolani HE, Rebolledo OR, Portiansky EL, Pérez NG, Camilión de Hurtado MC. Cingolani HE, et al. Hypertension. 2003 Feb;41(2):373-7. doi: 10.1161/01.hyp.0000051502.93374.1c. Hypertension. 2003. PMID: 12574110 - Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart.
Vatner DE, Asai K, Iwase M, Ishikawa Y, Shannon RP, Homcy CJ, Vatner SF. Vatner DE, et al. Am J Cardiol. 1999 Jun 17;83(12A):80H-85H. doi: 10.1016/s0002-9149(99)00266-0. Am J Cardiol. 1999. PMID: 10750593 Review. - Is timing everything? Therapeutic potential of modulators of cardiac Na(+) transporters.
Doggrell SA, Hancox JC. Doggrell SA, et al. Expert Opin Investig Drugs. 2003 Jul;12(7):1123-42. doi: 10.1517/13543784.12.7.1123. Expert Opin Investig Drugs. 2003. PMID: 12831348 Review.
Cited by
- Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2.
Chen S, Wang Q, Bakker D, Hu X, Zhang L, van der Made I, Tebbens AM, Kovácsházi C, Giricz Z, Brenner GB, Ferdinandy P, Schaart G, Gemmink A, Hesselink MKC, Rivaud MR, Pieper MP, Hollmann MW, Weber NC, Balligand JL, Creemers EE, Coronel R, Zuurbier CJ. Chen S, et al. Basic Res Cardiol. 2024 Oct;119(5):751-772. doi: 10.1007/s00395-024-01067-9. Epub 2024 Jul 24. Basic Res Cardiol. 2024. PMID: 39046464 Free PMC article. - Effects of combined inhibition of the Na+-H+ exchanger and angiotensin-converting enzyme in rats with congestive heart failure after myocardial infarction.
Ruetten H, Gehring D, Hiss K, Schindler U, Gerl M, Busch AE, Schaefer S. Ruetten H, et al. Br J Pharmacol. 2005 Nov;146(5):723-31. doi: 10.1038/sj.bjp.0706381. Br J Pharmacol. 2005. PMID: 16151439 Free PMC article. - Structure of human Na+/H+ exchanger NHE1 regulatory region in complex with calmodulin and Ca2+.
Köster S, Pavkov-Keller T, Kühlbrandt W, Yildiz Ö. Köster S, et al. J Biol Chem. 2011 Nov 25;286(47):40954-61. doi: 10.1074/jbc.M111.286906. Epub 2011 Sep 19. J Biol Chem. 2011. PMID: 21931166 Free PMC article. - Dietary Omega-3 Polyunsaturated Fatty Acids Suppress NHE-1 Upregulation in a Rabbit Model of Volume- and Pressure-Overload.
van Borren MM, den Ruijter HM, Baartscheer A, Ravesloot JH, Coronel R, Verkerk AO. van Borren MM, et al. Front Physiol. 2012 Apr 2;3:76. doi: 10.3389/fphys.2012.00076. eCollection 2012. Front Physiol. 2012. PMID: 22485092 Free PMC article. - Na(+)/H(+) exchanger 1 directly binds to calcineurin A and activates downstream NFAT signaling, leading to cardiomyocyte hypertrophy.
Hisamitsu T, Nakamura TY, Wakabayashi S. Hisamitsu T, et al. Mol Cell Biol. 2012 Aug;32(16):3265-80. doi: 10.1128/MCB.00145-12. Epub 2012 Jun 11. Mol Cell Biol. 2012. PMID: 22688515 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous